Following an investigation by Harvard Health care School and Brigham and Women’s Hospital a 2012 paper published in Circulation has been retracted. The “institutional review… established that the data are sufficiently compromised that a retraction is warranted.” The two senior authors of the paper are Piero Anversa, a pioneering researcher in cardiac stem cells, and Joseph Loscalzo, the editor-in-chief of Circulation and the chairman of the division of medication at the Brigham.
As reported earlier on Retraction Observe, the paper has been cited thirty times according to Thomson Scientific’s Net of Knowledge.
Right here is the retraction statement:
For the write-up by Jan Kajstura, Marcello Rota, Donato Cappetta, Barbara Ogórek, Christian Arranto, Yingnan Bai, João Ferreira Martins, Sergio Signore, Fumihiro Sanada, Alex Matsuda, James Kostyla, Maria-Virginia Caballero, Claudia Fiorini, David A. D’Alessandro, Robert E. Michler, Federica del Monte, Toru Hosoda, Mark A. Perrella, Annarosa Leri, Bruce A. Buchholz, Joseph Loscalzo, and Piero Anversa (Cardiomyogenesis in the aging and failing human heart. Circulation. 2012126:18691881 DOI: 10.1161/CIRCULATIONAHA.112.118380), an ongoing institutional evaluation by Harvard Healthcare College and Brigham and Women’s Hospital has established that the data are sufficiently compromised that a retraction is warranted.
The American Heart Association American Heart Association, as a result, retracts the write-up.
A 2011 weblog on Nature.com thorough some of the events in a prolonged-standing controversy in excess of Anversa’s research.
Circulation Retracts Paper By Stem Cell Pioneer And Its Personal Editor
Hiç yorum yok:
Yorum Gönder